Nplate is approved only for patients with chronic ITP who do not respond sufficiently to current treatments.
Nplate只是被批准用于那些对于目前的治疗方法无反应得慢性ITP患者。
The estimated 140,000 people with chronic ITP are prone to bruising and at risk for life-threatening bleeding.
估计有14万慢性ITP患者很容易擦伤，并且有危及生命的出血风险。
Conclusion: The condition of chronic ITP patients is positively relative to the contents of haematoblast related antibodies in the serum.
结论：ITP患者病情与血清中血小板相关抗体的含量呈正相关；
In patients with chronic ITP, the immune system is believed to destroy platelets and the patient's bone marrow is often unable to compensate for this loss.
在慢性ITP患者中，免疫系统在破坏血小板，而病人的骨髓增生往往是无法弥补这一损失。
Objective the aim of this study was to review the safety and efficacy of elective splenectomy in children with chronic idiopathic thrombocytopenic purpura (ITP).
目的探讨近年来儿童慢性特发性血小板减少性紫癜(itp)患者行选择性脾切除术的有效性及安全性。
Conclusions Elective splenectomy is a safe and effective procedure for children with chronic or refractory ITP.
结论选择性脾切除术是治疗儿童慢性ITP安全有效的方法。
Objective: to explore the optimal doses of Fuzheng-Kangdian decoction in treating chronic idiopathic thrombocytopenic purpura (ITP).
目的：筛选扶正抗癜汤治疗慢性特发性血小板减少性紫癜(itp)的最佳剂量配比。
Objective: to explore the optimal doses of Fuzheng-Kangdian decoction in treating chronic idiopathic thrombocytopenic purpura (ITP).
目的：筛选扶正抗癜汤治疗慢性特发性血小板减少性紫癜(itp)的最佳剂量配比。
应用推荐